NT5E and cancer: Here, we describe a new CD73 blocking monoclonal antibody, 22E6, which effectively inhibits the enzymatic activity of the membrane-tethered form of human CD73 (mCD73) on cancer cells and tumor-derived extracellular vesicles at nanomolar concentrations.